Source: Brazilian Journal of Psychiatry. Unidade: FMRP
Subjects: ESQUIZOFRENIA, BIOMARCADORES, MODELOS ANIMAIS DE DOENÇAS
ABNT
NANI, João Victor et al. Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity. Brazilian Journal of Psychiatry, 2024Tradução . . Disponível em: https://doi.org/10.47626/1516-4446-2023-3315. Acesso em: 17 nov. 2024.APA
Nani, J. V., Ushirohira, J. M., Bradshaw, N. J., Machado-de-Sousa, J. P., Hallak, J. E. C., & Hayashi, M. A. (2024). Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity. Brazilian Journal of Psychiatry. doi:10.47626/1516-4446-2023-3315NLM
Nani JV, Ushirohira JM, Bradshaw NJ, Machado-de-Sousa JP, Hallak JEC, Hayashi MA. Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity [Internet]. Brazilian Journal of Psychiatry. 2024 ;[citado 2024 nov. 17 ] Available from: https://doi.org/10.47626/1516-4446-2023-3315Vancouver
Nani JV, Ushirohira JM, Bradshaw NJ, Machado-de-Sousa JP, Hallak JEC, Hayashi MA. Sodium nitroprusside as an adjunctive treatment for schizophrenia reduces the Ndel1 oligopeptidase activity [Internet]. Brazilian Journal of Psychiatry. 2024 ;[citado 2024 nov. 17 ] Available from: https://doi.org/10.47626/1516-4446-2023-3315